Pure red cell aplasia following pegylated interferon alpha treatment.
Publication
, Journal Article
Arcasoy, MO; Rockey, DC; Heneghan, MA
Published in: Am J Med
October 15, 2004
Duke Scholars
Published In
Am J Med
DOI
ISSN
0002-9343
Publication Date
October 15, 2004
Volume
117
Issue
8
Start / End Page
619 / 620
Location
United States
Related Subject Headings
- Red-Cell Aplasia, Pure
- Recombinant Proteins
- Postoperative Complications
- Polyethylene Glycols
- Middle Aged
- Liver Transplantation
- Interferon-alpha
- Interferon alpha-2
- Humans
- Hepatitis C
Citation
APA
Chicago
ICMJE
MLA
NLM
Arcasoy, M. O., Rockey, D. C., & Heneghan, M. A. (2004). Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med, 117(8), 619–620. https://doi.org/10.1016/j.amjmed.2004.04.023
Arcasoy, Murat O., Don C. Rockey, and Michael A. Heneghan. “Pure red cell aplasia following pegylated interferon alpha treatment.” Am J Med 117, no. 8 (October 15, 2004): 619–20. https://doi.org/10.1016/j.amjmed.2004.04.023.
Arcasoy MO, Rockey DC, Heneghan MA. Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med. 2004 Oct 15;117(8):619–20.
Arcasoy, Murat O., et al. “Pure red cell aplasia following pegylated interferon alpha treatment.” Am J Med, vol. 117, no. 8, Oct. 2004, pp. 619–20. Pubmed, doi:10.1016/j.amjmed.2004.04.023.
Arcasoy MO, Rockey DC, Heneghan MA. Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med. 2004 Oct 15;117(8):619–620.
Published In
Am J Med
DOI
ISSN
0002-9343
Publication Date
October 15, 2004
Volume
117
Issue
8
Start / End Page
619 / 620
Location
United States
Related Subject Headings
- Red-Cell Aplasia, Pure
- Recombinant Proteins
- Postoperative Complications
- Polyethylene Glycols
- Middle Aged
- Liver Transplantation
- Interferon-alpha
- Interferon alpha-2
- Humans
- Hepatitis C